Forte Biosciences
FBRX
57 hedge funds and large institutions have $12.8M invested in Forte Biosciences in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 38 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 14
1.44% less ownership
Funds ownership: 2.55% → 1.11% (-1.4%)
24% less funds holding
Funds holding: 75 → 57 (-18)
45% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 38
53% less call options, than puts
Call options by funds: $1.32M | Put options by funds: $2.8M
96% less capital invested
Capital invested by funds: $289M → $12.8M (-$276M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$10.8M |
| 2 |
State Street
Boston,
Massachusetts
|
+$6.26M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.97M |
| 4 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
+$3.12M |
| 5 |
Jane Street
New York
|
+$2.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$40.9M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$39.8M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$25.6M |
| 4 |
PA
Perceptive Advisors
New York
|
-$23M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$22.5M |
FBRX Hedge Fund Activity: Q3 2021 in Review
57 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q3 2021, worth a combined $12.8M — down 96% from $289M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of FBRX and 21 opened new positions — a net loss of 17 holders — while 14 trimmed existing stakes and 16 added.
The largest buyer was Millennium Management, adding an estimated $10.8M. The largest seller was Fred Alger Management, exiting entirely with an estimated $40.9M sold.
- 57 institutional investors held Forte Biosciences (FBRX) as of Q3 2021, down from 75 in Q2 2021.
- Funds reported $12.8M of Forte Biosciences stock for Q3 2021, down 96% quarter-over-quarter.
- 21 funds opened new Forte Biosciences positions in Q3 2021 and 38 closed out, a net change of -17 holders.
- The largest Forte Biosciences buyer in Q3 2021 was Millennium Management, an estimated $10.8M added.
- The largest Forte Biosciences seller in Q3 2021 was Fred Alger Management, an estimated $40.9M sold.
Based on aggregated 13F filings for Q3 2021.